HKU Scholars Hub: Browsing DSpace

Browsing by Author Yuen, JCH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 43 to 62 of 75 < previous next >

Title	Author(s)	Issue Date	Views
Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir Journal:Antiviral Therapy	Seto, WK Liu, K Fung, J Wong, DKH Yuen, JCH Hung, IFN Lai, CL Yuen, MF	2012	75
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection Proceeding/Conference:Hepatology	Yuen, RMF Kim, J Averett, D Wong, DKH Kim, CR Kerr, B Ngai, WS Yuen, JCH Lai, CL	2004	131
A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection Proceeding/Conference:Antiviral Research	Yuen, RMF Kim, J Wong, DKH Ngai, WS Yuen, JCH Lai, CL	2003	74
Pin1 over-expression and β-catenin gene mutations are distinct oncogenic events in human hepatocarcinogenesis. Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2003	Pang, RWC Yuen, JCH Yuen, RMF Lai, CL Kwong, YL Tse, EWC	2003	78
Predictive model for fibrosis and cirrhosis in chronic hepatitis B using liver stiffness measurement Proceeding/Conference:Hepatology	Fung, JYY Lai, CL Fong, DYT Yuen, JCH Wong, DKH Yuen, RMF	2007	108
Predictive value of HBV DNA levels at frequent time points during early and maintenance phase of 5-year laminudine and mutational profiles of reverse transcriptase (RT) and surface (S) genes Proceeding/Conference:Hepatology	Yuen, RMF Wong, DKH Fung, JYY Yuen, JCH Lai, CL	2006	132
Prevalence and significance of hepatitis GB virus-C/hepatitis G virus viremia in a large cohort of patients with chronic hepatitis B infection, with chronic hepatitis C infection, and on renal replacement therapy in Hong Kong Journal:Digestive Diseases and Sciences	Yuen, MF Chan, TM Terence PokSiu, YIP Yuen, JCH Ho, SKN Lai, CL	2002	118
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: A study of a large blood donor population Journal:Gut	Yuen, MF Lee, CK Wong, DKH Fung, J Hung, I Hsu, A But, DYK Cheung, TK Chan, P Yuen, JCH Fung, FKC Seto, WK Lin, CK Lai, CL	2010	152
Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion Proceeding/Conference:Hepatology	Fung, JYY Lai, CL Tanaka, Y Mizokami, M Yuen, JCH Wong, DKH Yuen, RMF	2007	81
Profound reduction of HBV covalently closed circular DNA with long-term nucleoside/tide analogue therapy Proceeding/Conference:Hepatology	Lai, CL Wong, DKH Ip, P Kopaniszen, M Seto, WK Fung, J Huang, FY Lee, BP Cullaro, G Wu, CH Cheng, C Yuen, JCH Ngai, V Yuen, MF	2014	90
Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications Journal:Gut	Yuen, MF Yuan, HJ Wong, DKH Yuen, JCH Wong, WM Chan, AOO Wong, BCY Lai, KC Lai, CL	2005	137
Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma Journal:Journal of Hepatology	Wong, DKH Yuen, MF Poon, RTP Yuen, JCH Fung, J Lai, CL	2006	168
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B Journal:Antiviral Therapy	Yuen, MF Kim, J Kim, CR Ngai, V Yuen, JCH Min, C Kang, HM Shin, BS Yoo, SD Lai, CL	2006	122
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable cccDNA Proceeding/Conference:Hepatology	Lai, CL Wong, DKH Yuen, JCH Wu, CH Cheng, CTK Ngai, WS Kopaniszen, M Seto, WKW Fung, JYY Yuen, RMF	2017	60
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B Journal:Journal of Hepatology	Lai, CL Wong, DKH Ip, PCP Kopaniszen, M Seto, WKW Fung, JYY Huang, FY Lee, B Cullaro, G Chong, CK Wu, CH Cheng, CTK Yuen, JCH Ngai, WS Yuen, RMF	2017	83
Reduction of hepatitis B core related antigen by long term nucleoside nucleotide analogue therapy and its correlation with intrahepatic HBV DNA reduction Proceeding/Conference:Hepatology International	Wong, D Kopaniszen, M Seto, WK Fung, J Hung, I Young, JLP Yuen, JCH Ngai, VWS Yuen, MF Lai, CL	2015	194
Risk factors and post-resection independent predictive score for the recurrence of hepatitis B-related hepatocellular carcinoma Proceeding/Conference:Hong Kong Medical Journal	Hung, IFN Wong, DKH Poon, RTP Fong, DYT Chui, AHW Seto, WK Fung, JYY Chan, ACY Yuen, JCH Tiu, R Choi, O Lai, CL Yuen, MF	2015	42
Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Journal:PLoS ONE	Hung, FNI Wong, DKH Poon, RTP Fong, DYT Chui, AHW Seto, WKW Fung, JYY Chan, ACY Yuen, JCH Tiu, TMRJ CHOI, MYO Lai, CL Yuen, RMF	2016	79
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels Journal:Gut	Yuen, MF Tanaka, Y Shinkai, N Poon, RT But, DYK Fong, DYT Fung, J Wong, DKH Yuen, JCH Mizokami, M Lai, CL	2008	117
Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesis Proceeding/Conference:Journal of Hepatology	Yuen, RMF Tanaka, Y Shinkai, N Poon, RTP Fung, JYY Wong, DKH Yuen, JCH Mizokami, M Lai, CL	2007	167

Showing results 43 to 62 of 75 < previous next >